:COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES

DEFINITIVE CONTRACT won by GLAXOSMITHKLINE, LLC · work in DURHAM, NC
$1,596,901,996
RecipientGLAXOSMITHKLINE, LLC UEI FRHTPHMZMX47
Award IDW58P0522C0002
Award amount$1,596,901,996
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Department of the Army
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateNov 15, 2021
End dateMar 31, 2023
Place of performanceDURHAM, NC
Record updatedSep 15, 2022

View the official award record

More awards won by GLAXOSMITHKLINE, LLC

GLAXOSMITHKLINE ADJUVANT AS03
Department of Defense · $346,055,756 · Jul 30, 2020
:COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
Department of Defense · $279,862,800 · Sep 24, 2021
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Department of Health and Human Services · $45,499,950 · Sep 30, 2025
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.
Department of Health and Human Services · $22,877,697 · Sep 14, 2022
8508921650!INFLUENZA VIRUS VAC
Department of Defense · $18,846,168 · Aug 31, 2022

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids